Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-marketing Observational Study for Venetoclax in Patients Diagnosed With Acute Myeloid Leukemia in Japan

NCT04813263 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04813263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04813263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-marketing Observational Study for Venetoclax in Patients Diagnosed With Acute Myeloid Leukemia in Japan
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
May 28, 2021
Completion date
April 30, 2024
Enrollment
424 (actual)
Sites
281

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml)